PPARG and chronic granulomatous disease: Treatment with the PPARγ agonist pioglitazone in a mouse model of chronic granulomatous disease (CGD; NADPH deficiency) with S. aureus infection restored reactive oxygen species (ROS) production by mitochondria in blood monocytes and tissue macrophages [56].